Leaders from the Indiana Biosciences Research Institute believe a recent $750,000 grant secured by one of its researchers could help spark other activity in the future. The funding from the Juvenile Diabetes Research Foundation will support Teresa Mastracci’s work involving treatments to slow or stop the progression of Type 1 diabetes. In an interview with Inside INdiana Business, the IBRI’s Christy Denault says the grant is a "feather in our cap" for attracting additional investment and research talent.
The institute is touted as the first-of-its-kind in the nation and is expected to attract some $360 million in investment. It is the anchor of the 16 Tech Biotechnology Research & Training Center, an innovation cluster being developed along the White River near the IUPUI campus. She tells Inside INdiana Business the fledgling, industry-driven nonprofit is continuing to gain momentum. "Right now, the IBRI is building a lot of capacity in terms of talent. We’re also working hard to pull together the funding we need to make this a sustainable model going forward," Denault says. "By the end of the year, I think the picture that we can paint from the IBRI will be very different from the one we see today."
In all, the IBRI is planning to include 100,000 square-feet of research and office space and will receive much of its funding through the private sector.